29 Aug Doyle announces $750,000 award for Stratatech
Madison, Wis. – One week after securing a federal research grant, Stratatech Corp. has received a $750,000 state grant award to help develop new, genetically-enhanced human skin substitutes to heal wounds.
Stratatech, which last week landed a $1.45 million grant from the National Institute on Aging, has been awarded the state grant based on its potential to achieve life-saving breakthroughs, according to Gov. Jim Doyle.
“Biotechnology is a competitive industry and Wisconsin still has a lead, but we need to continue to support these efforts in a significant way at the state level,” Doyle said in a release.
Stratatech is a regenerative medicine company focused on the development of cell-based, tissue-engineered products that promote the healing of chronic skin ulcers. The company, founded in 2000, is developing products that have been genetically enhanced to express natural, human wound-healing factors that reduce infection and improve blood flow to the wound.
The state grant is from the Technology Development Fund program within the Wisconsin Department of Commerce.
• Stratatech Corp. lands another federal research grant
• Venture-backed firms could become eligible for federal SBIR grants
• Stratatech Receives another NIH Grant
• Stratatech Receives $4 Million Federal Grant